Riskpilot← Back to searchSign inGet full accessGULLEGG AS
ASActiveOrg 922544115Geir Liang Torvmarkvegen 15, 7540 KlæbuMedical specialists activities · NACE 8622Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
-29% vs 2023
Equity ratio
-0.5%
Financial strength
Net profit 2024
NOK -15K
-31% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -16K | -29% |
| Net profit | NOK -15K | -31% |
| Total assets | NOK 4,9M | +14% |
| Equity | NOK -23K | -185% |
| Employees | 0 | — |
Legal name
GULLEGG AS
Org number
922544115
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
9. april 2019
Share capital
NOK 30 520
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Investeringsvirksomhet og dertil hørende virksomhet. Herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak
Address
Geir Liang Torvmarkvegen 15, 7540 Klæbu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −5 | 0 | −25 | −10 | −13 | −16 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −5 | 0 | −25 | −10 | −13 | −16 |
| Net financials | 0 | 0 | 15 | 4 | 1 | 2 |
| Profit before tax | −5 | 0 | −11 | −6 | −11 | −15 |
| Tax | 1 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 | 0 | −11 | −6 | −11 | −15 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 3 835 | 3 732 | 7 158 | 5 286 | 4 261 | 4 859 |
| Equity | 20 | 20 | 9 | 3 | −8 | −23 |
| Long-term debt | 3 815 | 3 712 | 3 790 | 3 822 | 3 776 | 3 776 |
| Short-term debt | 0 | 0 | 3 358 | 1 461 | 493 | 1 106 |
| Total debt | 3 815 | 3 712 | 7 148 | 5 282 | 4 269 | 4 881 |
EBITDA margin
-1630400.0%
This company
15.8%
Market median
-10319087% vs market
20192024
Equity ratio
-0.5%
This company
38.2%
Market median
-101% vs market
20192024
Return on equity
-1478400.0%
This company
18.4%
Market median
-8034883% vs market
20192024
Net profit margin
-1478400.0%
This company
8.1%
Market median
-18251952% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
214.16×
This company
0.62×
Market median
-34442% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Liang Invest As | Company | 81.5% | 81.5% | 2022 |
Crear As | Company | 10.8% | 10.8% | 2022 |
Rullebu As | Company | 7.7% | 7.7% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rullebu As
GULLEGG AS Board members of GULLEGG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Liang | Chairman | 0 companies |
| Runar Jensen | Board of Directors | 0 companies |